CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Temporary Equity, Foreign Currency Translation Adjustments
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Temporary Equity, Foreign Currency Translation Adjustments of -$1.20 million for the 12-month period ending 2023-12-30, per its 10-K filed 2024-02-14.
Discontinued › Shareholders' Equity
us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments · last filed 2024-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, foreign currency translation adjustments for the quarter ending 2023-12-30 was $1.15M, a 14.04% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, foreign currency translation adjustments for the quarter ending 2023-09-30 was -$192.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, foreign currency translation adjustments for the quarter ending 2023-07-01 was -$2.35M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, foreign currency translation adjustments for the quarter ending 2023-04-01 was $186.00K, a 4550.00% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, foreign currency translation adjustments for fiscal 2023 was -$1.20M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, foreign currency translation adjustments for fiscal 2022 was -$3.58M, a 534.95% decline from fiscal 2021.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, foreign currency translation adjustments for fiscal 2021 was $824.00K, a 42.62% decline from fiscal 2020.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, foreign currency translation adjustments for fiscal 2020 was $1.44M.
| Period end | Temporary Equity, Foreign Currency Translation Adjustments 3 month | Temporary Equity, Foreign Currency Translation Adjustments 6 month | Temporary Equity, Foreign Currency Translation Adjustments 9 month | Temporary Equity, Foreign Currency Translation Adjustments 12 month |
|---|---|---|---|---|
| 2023-12-30 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $959.00K derived: sum of 2 quarters · filed 2024-02-14 | -$1.39M derived: sum of 3 quarters · filed 2024-02-14 | -$1.20M 10-K · filed 2024-02-14 |
| 2023-09-30 | -$192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.54M derived: sum of 2 quarters · filed 2023-11-08 | -$2.35M 10-Q · filed 2023-11-08 | -$1.01M derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-07-01 | -$2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.16M 10-Q · filed 2023-08-09 | -$820.00K derived: sum of 3 quarters · filed 2024-02-14 | -$3.13M derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-04-01 | $186.00K 10-Q · filed 2023-05-11 | $1.52M derived: sum of 2 quarters · filed 2024-02-14 | -$785.00K derived: sum of 3 quarters · filed 2024-02-14 | -$3.40M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$971.00K derived: sum of 2 quarters · filed 2024-02-14 | -$3.59M derived: sum of 3 quarters · filed 2024-02-14 | -$3.58M 10-K · filed 2024-02-14 |
| 2022-09-24 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$4.93M derived: sum of 2 quarters · filed 2023-11-08 | -$4.92M 10-Q · filed 2023-11-08 | -$4.44M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-25 | -$2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.61M 10-Q · filed 2023-08-09 | -$2.13M derived: sum of 3 quarters · filed 2024-02-14 | -$2.15M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-26 | $4.00K 10-Q · filed 2023-05-11 | $488.00K derived: sum of 2 quarters · filed 2024-02-14 | $468.00K derived: sum of 3 quarters · filed 2024-02-14 | $843.00K derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-25 | $484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $464.00K derived: sum of 2 quarters · filed 2024-02-14 | $839.00K derived: sum of 3 quarters · filed 2024-02-14 | $824.00K 10-K · filed 2024-02-14 |
| 2021-09-25 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $355.00K derived: sum of 2 quarters · filed 2022-11-02 | $340.00K 10-Q · filed 2022-11-02 | $1.38M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-26 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $360.00K 10-Q · filed 2022-08-03 | $1.40M derived: sum of 3 quarters · filed 2023-02-22 | $2.29M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-27 | -$15.00K 10-Q · filed 2022-05-04 | $1.02M derived: sum of 2 quarters · filed 2023-02-22 | $1.91M derived: sum of 3 quarters · filed 2023-02-22 | $1.97M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-26 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.93M derived: sum of 2 quarters · filed 2023-02-22 | $1.98M derived: sum of 3 quarters · filed 2023-02-22 | $1.44M 10-K · filed 2023-02-22 |
| 2020-09-26 | $889.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $940.00K derived: sum of 2 quarters · filed 2021-11-03 | $396.00K 10-Q · filed 2021-11-03 | $989.00K derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-27 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$493.00K 10-Q · filed 2021-08-04 | $100.00K derived: sum of 3 quarters · filed 2021-08-04 | -$679.00K derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-28 | -$544.00K 10-Q · filed 2021-05-04 | $49.00K derived: sum of 2 quarters · filed 2021-05-04 | -$730.00K derived: sum of 3 quarters · filed 2021-05-04 | -$1.22M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-28 | $593.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | -$186.00K derived: sum of 2 quarters · filed 2021-02-17 | -$679.00K derived: sum of 3 quarters · filed 2021-02-17 | -$221.00K 10-K · filed 2021-02-17 |
| 2019-09-28 | -$779.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$1.27M derived: sum of 2 quarters · filed 2020-10-29 | -$814.00K 10-Q · filed 2020-10-29 | -$835.00K derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-29 | -$493.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$35.00K 10-Q · filed 2020-08-05 | -$56.00K derived: sum of 3 quarters · filed 2020-08-05 | -$664.00K derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-30 | $458.00K 10-Q · filed 2020-05-07 | $437.00K derived: sum of 2 quarters · filed 2020-05-07 | -$171.00K derived: sum of 3 quarters · filed 2020-05-07 | -$1.06M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-29 | -$21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | -$629.00K derived: sum of 2 quarters · filed 2020-02-11 | -$1.52M derived: sum of 3 quarters · filed 2020-02-11 | -$953.00K 10-K · filed 2020-02-11 |
| 2018-09-29 | -$608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$1.50M derived: sum of 2 quarters · filed 2019-11-06 | -$932.00K 10-Q · filed 2019-11-06 | -$550.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | -$888.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$324.00K 10-Q · filed 2019-07-31 | $58.00K derived: sum of 3 quarters · filed 2019-07-31 | $343.00K derived: sum of 4 quarters · filed 2019-07-31 |
| 2018-03-31 | $564.00K 10-Q · filed 2019-05-07 | $946.00K derived: sum of 2 quarters · filed 2019-05-07 | $1.23M derived: sum of 3 quarters · filed 2019-05-07 | $1.48M derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-30 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $667.00K derived: sum of 2 quarters · filed 2019-02-13 | $917.00K derived: sum of 3 quarters · filed 2019-02-13 | $1.03M 10-K · filed 2019-02-13 |
| 2017-09-30 | $285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $535.00K derived: sum of 2 quarters · filed 2018-11-07 | $652.00K 10-Q · filed 2018-11-07 | |
| 2017-07-01 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $367.00K 10-Q · filed 2018-08-08 | ||
| 2017-04-01 | $117.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | -$818.00K 10-K · filed 2019-02-13 | |||
| 2016-09-24 | -$222.00K derived: 10-Q 9 month − 10-K 6 month · filed 2017-11-09 | -$689.00K derived: sum of 2 quarters · filed 2019-02-13 | -$875.00K 10-Q · filed 2017-11-09 | |
| 2016-07-07 | -$467.00K derived: 10-K 6 month − 10-Q 3 month · filed 2019-02-13 | -$653.00K 10-K · filed 2019-02-13 | ||
| 2016-06-25 | -$467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$653.00K 10-Q · filed 2017-08-09 | ||
| 2016-03-26 | -$186.00K 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |